Chieko Asakawa, IBM Fellow and director of the Miraikan (Tokyo) National Museum of Emerging Science and Innovation, who develops technology to support the visually impaired, gave a lecture at Kyoto Lighthouse in Kita-ku, Kyoto City. She touched on her latest projects, such as the “AI suitcase” that will be tested at next year’s Osaka-Kansai Expo.
Speaking at a press conference after the settlement was reached, Keiko Onoue said “I kept silent for about 50 years because there were no people to discuss it with…Now that a new relief law has been created, I hope more victims can come forward.”
Japan’s health ministry is considering raising the caps on out-of-pocket payments patients make to hospitals under the public health insurance system. The ministry hopes to begin discussions on the issue soon and decide a basic course of action within this year at the earliest.
As Kagawa’s prefectural disability support facilities are aging, a study group of experts was held at the prefectural office to make the facilities more comfortable for users, and presented a draft report that includes the prefecture’s plan to make the facilities barrier-free. A total of 13 people, including experts and facility representatives, attended the study group on the 18th and exchanged opinions based on the draft report compiled by the prefecture on the future of prefectural disability support facilities. Professor Nozaki Akihiro of Shikoku Gakuin University, who serves as chairman of the study group, said, “Even if private facilities are no longer able to provide support, prefectural facilities need to maintain their function of protecting the rights and livelihoods of users as a last resort.”
A settlement was reached on Friday 15th November at the Nagoya High Court in central Japan in a damages lawsuit over forced sterilization under the now-defunct eugenic protection law, ending a series of similar lawsuits in the country, according to the defense lawyers. The Nagoya lawsuit was filed by Keiko Onoue, 74, and her husband, Kazutaka, 77, against the Japanese government. The settlement terms are based on an agreement reached between the two sides in September. Speaking at a press conference after the settlement was reached, Keiko Onoue said “I kept silent for about 50 years because there were no people to discuss it with…Now that a new relief law has been created, I hope more victims can come forward.”
A settlement was reached on Friday 15th November at the Nagoya High Court in central Japan in a damages lawsuit over forced sterilization under the now-defunct eugenic protection law. After the settlement was reached, the plaintiff, Keiko Onoue (74) spoke about how she “kept silent for 50 years” as there was no one with whom she could “discuss” it. Speaking at a press conference after the settlement was reached, Keiko Onoue said “I kept silent for about 50 years because there were no people to discuss it with…Now that a new relief law has been created, I hope more victims can come forward.”
A settlement was reached Friday at Nagoya High Court in central Japan in a damages lawsuit over forced sterilization under the now-defunct eugenic protection law, ending a series of similar lawsuits in the country, according to the defense lawyers. The Nagoya lawsuit was filed by Keiko Onoue, 74, and her husband, Kazutaka, 77, against the Japanese government. The settlement terms are based on an agreement reached between the two sides in September.
Japanese digital minister Masaaki Taira reiterated that the government will stop issuing new health insurance cards on Dec. 2 as planned in a move to integrate them into “My Number” electronic personal identification cards. “There is no change in our policy to proceed (with the abolition) as scheduled,” Taira said in a recent interview. At the same time, Taira underscored the importance of the government making efforts to eliminate public distrust in problem-prone My Number cards.
The European Medicines Agency said Thursday that its committee evaluating medical products has recommended partial approval of sales of lecanemab to treat Alzheimer’s disease. The committee of the pharmaceuticals watchdog had shown a negative opinion in July on the medicine, developed by drugmakers Eisai Co. of Japan and Biogen Inc. of the United States.
Barrier Free Japan has noticed a number of adverts and leaflets at train stations of late. Specifically they are aimed at discouraging people from walking on escalators or walking whilst looking at their smartphones.
Barrier Free Japan